Trial Profile
A Randomized Double-Blind Placebo Controlled Multi-Center Study to Evaluate the Safety and Efficacy of Botulinum Neurotoxin Type A in the Treatment of Forward Head Posture With Associated Episodic Headache Disorder.
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 13 Sep 2019
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Headache disorders
- Focus Adverse reactions; Therapeutic Use
- 09 Sep 2019 Status changed from recruiting to completed.
- 11 May 2011 New trial record